好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2008 Annual Meeting | Autonomic Disorders

Tuesday 04/15/08
03:45 PM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Autonomic Disorders
No CME available
Event Timeline
03:45 PM - 05:00 PM Abstract 001 - Loss of A5 Noradrenergic Neurons in Multiple System Atrophy and Lewy Body Disease
03:45 PM - 05:00 PM Abstract 002 - Autoimmune Autonomic Failure: Successful Treatment by Total Plasma Exchange and Rituximab
03:45 PM - 05:00 PM Abstract 003 - Impaired Cardiac Uptake of (123)I-metaiodobenzylguanidine in Postural Tachycardia Syndrome
03:45 PM - 05:00 PM Abstract 004 - Influence of Hyperadrenergic State on the Valsalva Maneuver in Postural Tachycardia Syndrome
03:45 PM - 05:00 PM Abstract 005 - Peripheral Nerve Function in Diabetic Small Fiber Neuropathy
Faculty Disclosures
No disclosure on file
Eduardo E. Benarroch, MD, FAAN Dr. Benarroch has nothing to disclose.
Roy L. Freeman, MD Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Freeman has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurobo. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Freeman has stock in Neurobo. Dr. Freeman has stock in Cutaneous NeuroDiagnostics. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck.
Phillip A. Low, MD, FAAN Dr. Low has nothing to disclose.
Ronald Schondorf, MD No disclosure on file
Paola Sandroni, MD, PhD, FAAN Dr. Sandroni has nothing to disclose.
Steven Vernino, MD, PhD, FAAN Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron.
Joseph E. Parisi, MD Dr. Parisi has nothing to disclose.
Joel I. Shenker, MD, PhD, FAAN Dr. Shenker has received personal compensation for serving as an employee of R3 continuum. Dr. Shenker has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for attorneys.
David S. Goldstein, MD, PhD Dr. Goldstein has received publishing royalties from a publication relating to health care.
Ann M. Schmeichel Ann M. Schmeichel has nothing to disclose.
Christopher H. Gibbons, MD, FAAN Dr. Gibbons has received personal compensation for serving as an employee of CND Life Sciences. Dr. Gibbons has stock in CND Life Sciences. Dr. Gibbons has received publishing royalties from a publication relating to health care. Dr. Gibbons has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Advisor with Department of Justice.
Thu Nguyen, MD No disclosure on file
Carl-Albrecht Haensch, MD No disclosure on file
Oladi S. Bentho, MD Dr. Bentho has nothing to disclose.
Nobutoshi Kawamura No disclosure on file
Valeria Iodice The institution of Valeria Iodice has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance . The institution of Valeria Iodice has received research support from ACT, UCL.
Richard Imrich No disclosure on file
Rochelle T. Sweis, DO No disclosure on file
Maggie W. Waung, MD, PhD No disclosure on file
Simon Akerman, PhD No disclosure on file
Jorge G. Ortiz-Garcia, MD, FAAN Dr. Ortiz-Garcia has nothing to disclose.
Eugene L. Scharf, MD The institution of Dr. Scharf has received research support from American Brain Foundation. The institution of Dr. Scharf has received research support from NIH. Dr. Scharf has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Grand Rounds. Dr. Scharf has a non-compensated relationship as a Steering committee with Johnson and Johnson that is relevant to AAN interests or activities.
Sushma R. Yerram, MD Dr. Yerram has nothing to disclose.